LivaNova ticks higher amid vague takeover speculation

5.07BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
GB00BYMT0J19
CUSIP
G5509L101
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
26.00
PEG Ratio
0.93
Book Value
24.91
Dividend Share
-
Dividend Yield
-
Earnings Share
3.49
Wall Street Target Price
106.36
EPS Estimate Current Year
4.44
EPS Estimate Next Year
4.73
EPS Estimate Current Quarter
1.0591
EPS Estimate Next Quarter
1.0552
Most Recent Quarter
-
Revenue TTM
1,506,914,048
Gross Profit TTM
1,019,243,008
EBITDA
271,267,008
Profit Margin
13.01%
Return On Assets TTM
5.11%
Return On Equity TTM
15.50%
Revenue Per Share TTM
27.478
Qtly Revenue Growth YOY
9.90%
Diluted Eps TTM
3.49
Qtly Earnings Growth YOY
-78.20%
Trailing PE
26.00
Forward PE
18
Price Sales TTM
3.3167
Price Book MRQ
3.6983
Enterprise Value Revenue
3
Enterprise Value EBITDA
22
46.87
-3.03%23.29
-2.56%42.10
-2.43%28.61
-2.42%101.98
-2.07%80.84
-1.51%79.41
-1.30%309.53
-1.30%103.50
-0.81%100.15
-0.55%